Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Piedmont Pharmaceuticals LLC

www.piedmontanimalhealth.com

Latest From Piedmont Pharmaceuticals LLC

Can real world data talk to the money?

Over the past couple of years, real-world data (RWD) and real-world evidence (RWE) have emerged as key buzzwords along with big data, and we are set to hear even more of them, according to Richard Barker, director of the Centre for the Advancement of Sustainable Medical Innovation. Real-world studies (RWSs) are now becoming more common, but examples of their use and influence on reimbursement decisions or guidelines remain few and far between. Nevertheless, with their ability to demonstrate that a new intervention does work, after randomized controlled trials (RCTs) have shown that it can work, their use is growing, albeit in a fragmented and disconnected manner. These issues, along with other challenges relating to the use of RWD, were discussed at the eyeforpharma Real World Data Europe conference in London on 28–29 April 2014.

Neurology Spain

Market Insight - Alliances boost drug delivery as M&A and financing stall

Activity in the drug delivery sector has been geared towards alliances in 2009, says Phil Greenfield.

Gastrointestinal Metabolic Disorders

Commentary: Private investment round-up for April 2009

Investments in private pharmaceutical and biotech companies slumped by 24% in April, with the market being once again dominated by US companies, a Scrip analysis has found.

Respiratory Germany

PPD buys Magen BioSciences and sells anticancer research centre

PPD will expand into the dermatology market and move away from preclinical oncology research in a realignment towards its core operations.

Dermatology Companies
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Piedmont Pharmaceuticals LLC
  • Senior Management
  • Roland Johnson, Chmn. & CEO
    Michael F Kelly, CFO & COO
    Doug Hepler , PhD, CSO
    Eric Barnett , MD, EVP, Bus. Dev. & Mktg.
  • Contact Info
  • Piedmont Pharmaceuticals LLC
    Phone: (336) 544-0320
    204 Muirs Chapel Rd.
    Ste. 204
    Greensboro, NC 27410
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register